NCT07142512 Helping Couples Communicate Better: Does This Help Persons With Type 2 Diabetes Respond Better to a Step Count Prescription?
| NCT ID | NCT07142512 |
| Status | Recruiting |
| Phase | — |
| Sponsor | McGill University Health Centre/Research Institute of the McGill University Health Centre |
| Condition | Type 2 Diabetes |
| Study Type | INTERVENTIONAL |
| Enrollment | 200 participants |
| Start Date | 2025-10-01 |
| Primary Completion | 2027-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 200 participants in total. It began in 2025-10-01 with a primary completion date of 2027-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Being active is one way to reach better blood sugar control and heart health in type 2 diabetes. The investigators developed a strategy to help people with type 2 diabetes walk more. They track their steps with a step counter and set targets with their doctor through a kind of 'step prescription.' While this strategy helps people increase their physical activity, it can be useful to have support besides the clinic visits. Their partner might be a good person to help. Partners often have similar activity levels. Partners of people with type 2 diabetes are also more likely to develop type 2 diabetes. There are good reasons to work together! However, not all partners communicate in a way that helps them work together effectively. The investigators are going to give a step counter and step prescriptions to a large group of people with type 2 diabetes. The partners will also receive counters and step prescriptions. Half of the couples will be randomized (assigned to a group based on something equivalent to a coin toss) to participate in online or in-person sessions with a counselor. They will work together to figure out how to communicate more kindly and effectively. The investigators will see if the people with these sessions wind up having higher steps and better sugar control than the people who do not. To figure out in which types of couples the strategy works, The investigators will also divide the couples into groups based on the type of marriage that they have (figured out through a questionnaire) and body size. The investigators will see if the counseling strategy helps in both 'high' and 'low' quality relationships and if couples where both partners have extra weight respond differently to the strategy than other couples. During the trial, if The investigators see that the strategy is not working well in one particular group of people, The investigators may recruit fewer in this group and more in the others. The investigators will do this in consultation with specialized statisticians who will look at the data at specific points in time. This is a way of making sure that the investigators are testing the right strategy in the right group, increasing the 'efficiency' and relevance of the study.
Eligibility Criteria
Inclusion Criteria: * (i) Index participant has T2D; * (ii) Index participant 45 years of age or older; * (iii) Index participant and partner: Co-habiting with a partner (same or different sex) for two or more years; * (iv) Index participant and partner: Absence of gait difficulties or other co-morbid conditions that impede walking in the index participant; * (v) Willingness to complete an audiovisual recording of a conversation between the couple members to capture couple communication styles * (vi) Index participant and partner Smartphone and Internet access.
Contact & Investigator
Kaberi Dasgupta, MDCM, MSc, FRCPC
PRINCIPAL INVESTIGATOR
Research Institute of the McGill University Health Centre
Frequently Asked Questions
Who can join the NCT07142512 clinical trial?
This trial is open to participants of all sexes, aged 45 Years or older, studying Type 2 Diabetes. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07142512 currently recruiting?
Yes, NCT07142512 is actively recruiting participants. Contact the research team at debora.rosa@rimuhc.ca for enrollment information.
Where is the NCT07142512 trial being conducted?
This trial is being conducted at Montreal, Canada, Montreal, Canada, Montreal, Canada.
Who is sponsoring the NCT07142512 clinical trial?
NCT07142512 is sponsored by McGill University Health Centre/Research Institute of the McGill University Health Centre. The principal investigator is Kaberi Dasgupta, MDCM, MSc, FRCPC at Research Institute of the McGill University Health Centre. The trial plans to enroll 200 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.